US to pay over $1 bn for 100 mn doses of J&J's potential Covid-19 vaccine

The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, its latest such arrangement as the race to tame the pandemic intensifies, the drugmaker said on Wednesday.
 

It said it would deliver the vaccine to the Biomedical Advanced Research and Development Authority (BARDA) on a not-for-profit basis to be used after approval or emergency use authorization by the US Food and Drug Administration (FDA).
 

J&J has already received $1 billion in funding from the US
 

government - BARDA agreed in March to provide that money for the company to